(Updated - April 12, 2022 8:19 AM EDT)

Jefferies analyst Chris Howerton downgraded Landos Biopharma (NASDAQ: LABP) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE